Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) kicked off on Friday, down -26.09% from the previous trading day, before settling in for the closing price of $16.44. Over the past 52 weeks, CRBP has traded in a range of $4.64-$20.77.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 35.71%. While this was happening, its average annual earnings per share was recorded -68.54%. With a float of $10.80 million, this company’s outstanding shares have now reached $12.25 million.
The extent of productivity of a business whose workforce counts for 28 workers is very important to gauge.
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Corbus Pharmaceuticals Holdings Inc is 11.84%, while institutional ownership is 65.02%. The most recent insider transaction that took place on Oct 24 ’25, was worth 317,407. In this transaction Chief Executive Officer of this company sold 18,660 shares at a rate of $17.01, taking the stock ownership to the 138,187 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Chief Executive Officer sold 8,973 for $17.14, making the entire transaction worth $153,797. This insider now owns 138,187 shares in total.
Corbus Pharmaceuticals Holdings Inc (CRBP) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.15 earnings per share (EPS), lower than consensus estimate (set at -0.95) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -68.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -18.26% during the next five years compared to 35.71% growth over the previous five years of trading.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) Trading Performance Indicators
Take a look at Corbus Pharmaceuticals Holdings Inc’s (CRBP) current performance indicators. Last quarter, stock had a quick ratio of 9.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.76, a number that is poised to hit -1.66 in the next quarter and is forecasted to reach -5.15 in one year’s time.
Technical Analysis of Corbus Pharmaceuticals Holdings Inc (CRBP)
The latest stats from [Corbus Pharmaceuticals Holdings Inc, CRBP] show that its last 5-days average volume of 0.8 million was superior to 0.21 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.96%.
During the past 100 days, Corbus Pharmaceuticals Holdings Inc’s (CRBP) raw stochastic average was set at 39.23%, which indicates a significant increase from 6.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.72 in the past 14 days, which was higher than the 0.81 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.15, while its 200-day Moving Average is $9.26. Now, the first resistance to watch is $12.82. This is followed by the second major resistance level at $13.50. The third major resistance level sits at $14.11. If the price goes on to break the first support level at $11.53, it is likely to go to the next support level at $10.92. Assuming the price breaks the second support level, the third support level stands at $10.24.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) Key Stats
The company with the Market Capitalisation of 148.90 million has total of 12,255K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -40,210 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -17,660 K.
